ARCHIVES

Comprehensive Centers Could Lose That Designation By Not Producing

This article is from The Cancer Letter archive.

Vol. 01 No. 22 | May 30, 1975

Download PDF Visit The Full Archive

Related Articles

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

Trimodality Therapy Improves Survival In Early Disease

January 27, 2006

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

American Cancer Society Publishes CT Screening Guidelines for Lung Cancer

January 11, 2013

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994